CONCLUSION : We suggest that the increased risk of venous thromboembolism due to raloxifene treatment may be related to increased tPA levels , but not TAFI levels .
O O O O O O O O O B-DiseaseOrPhenotypicFeature I-DiseaseOrPhenotypicFeature O O B-ChemicalEntity O O O O O O B-GeneOrGeneProduct O O O O B-GeneOrGeneProduct O O